Gail T. McDonald

405 total citations
17 papers, 317 citations indexed

About

Gail T. McDonald is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Gail T. McDonald has authored 17 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Gail T. McDonald's work include Multiple Myeloma Research and Treatments (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Protein Degradation and Inhibitors (3 papers). Gail T. McDonald is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Protein Degradation and Inhibitors (3 papers). Gail T. McDonald collaborates with scholars based in Canada, Australia and United States. Gail T. McDonald's co-authors include Charles H. Graham, Lynne‐Marie Postovit, Shannyn K. Macdonald-Goodfellow, Stephen J. Renaud, David J. Sahn, Hugh D. Allen, Stanley J. Goldberg, Geneviève C. Paré, S Martin and Richard Sullivan and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Gail T. McDonald

16 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gail T. McDonald Canada 8 117 99 58 51 47 17 317
Jameel Singh United States 9 163 1.4× 211 2.1× 67 1.2× 37 0.7× 141 3.0× 16 445
Luis Sanfrutos Spain 11 80 0.7× 307 3.1× 51 0.9× 73 1.4× 88 1.9× 21 562
Ali Yavuzcan Türkiye 12 58 0.5× 210 2.1× 26 0.4× 31 0.6× 75 1.6× 48 389
Aida Moeini United States 14 32 0.3× 282 2.8× 88 1.5× 45 0.9× 69 1.5× 31 519
Kemal Beksaç Türkiye 10 39 0.3× 47 0.5× 30 0.5× 25 0.5× 35 0.7× 37 279
Bonnia Liu Australia 8 138 1.2× 202 2.0× 13 0.2× 38 0.7× 117 2.5× 15 326
Andrea Bosio Italy 11 45 0.4× 60 0.6× 26 0.4× 89 1.7× 64 1.4× 45 393
Letícia Gonçalves Freitas Brazil 10 110 0.9× 265 2.7× 16 0.3× 15 0.3× 139 3.0× 14 371
Francesca Colonese Italy 10 57 0.5× 47 0.5× 27 0.5× 64 1.3× 21 0.4× 24 367
Maria Komisarenko Canada 10 135 1.2× 221 2.2× 30 0.5× 112 2.2× 154 3.3× 25 524

Countries citing papers authored by Gail T. McDonald

Since Specialization
Citations

This map shows the geographic impact of Gail T. McDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail T. McDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail T. McDonald more than expected).

Fields of papers citing papers by Gail T. McDonald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail T. McDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail T. McDonald. The network helps show where Gail T. McDonald may publish in the future.

Co-authorship network of co-authors of Gail T. McDonald

This figure shows the co-authorship network connecting the top 25 collaborators of Gail T. McDonald. A scholar is included among the top collaborators of Gail T. McDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail T. McDonald. Gail T. McDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Venner, Christopher P., Richard LeBlanc, Irwindeep Sandhu, et al.. (2021). Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN‐003/MYX.1 single arm phase II trial. American Journal of Hematology. 96(5). 552–560. 12 indexed citations
3.
4.
Sridhar, Srikala S., Normand Blais, Ben Tran, et al.. (2020). Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer. JAMA Oncology. 6(11). 1751–1751. 25 indexed citations
5.
Reece, Donna, Andrea Kew, Marc Lalancette, et al.. (2019). Unusual Carfilzomib Toxicity: Three Cases of Drug-induced Thrombotic Microangiopathy (TMA) after Treatment with High-dose weekly Carfilzomib, Cyclophosphamide, and Dexamethasone (wCCD). Clinical Lymphoma Myeloma & Leukemia. 19(10). e272–e273. 4 indexed citations
6.
7.
Sridhar, Srikala S., Normand Blais, Ben Tran, et al.. (2018). Cctg BL12: Randomized phase II trial comparing nab-paclitaxel (Nab-P) to paclitaxel (P) in patients (pts) with advanced urothelial cancer progressing on or after a platinum containing regimen (NCT02033993).. Journal of Clinical Oncology. 36(15_suppl). 4505–4505. 6 indexed citations
8.
Venner, Christopher P., Richard LeBlanc, Irwindeep Sandhu, et al.. (2018). MCRN¯003/MYX·1: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma after 1-3 Prior Therapies. Blood. 132(Supplement 1). 1984–1984. 3 indexed citations
9.
10.
Monzon, Jose Gerard, Annette E. Hay, Gail T. McDonald, et al.. (2015). Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome. European Journal of Cancer. 51(17). 2501–2507. 19 indexed citations
11.
McDonald, Gail T., Richard Sullivan, Geneviève C. Paré, & Charles H. Graham. (2010). Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression. Experimental Cell Research. 316(19). 3197–3206. 30 indexed citations
12.
McDonald, Gail T.. (2008). INHIBITION OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) SIGNALLING LEADS TO RESISTANCE TO CHEMOTHERAPEUTIC AGENTS IN HUMAN CANCER CELLS. QSpace (Queen's University Library). 1 indexed citations
13.
Renaud, Stephen J., et al.. (2005). Activated Macrophages Inhibit Human Cytotrophoblast Invasiveness In Vitro1. Biology of Reproduction. 73(2). 237–243. 126 indexed citations
14.
Martin, S, et al.. (1999). Switching from depot antipsychotics to risperidone: results of a study of chronic schizophrenia. The Schizophrenia Treatment & Assessment Group.. PubMed. 16(2). 78–88. 30 indexed citations
15.
McDonald, Gail T., et al.. (1995). Effects of low-dose heparin on failure of intravenous infusions in children. Heart & Lung. 24(1). 79–82. 10 indexed citations
16.
Sahn, David J., et al.. (1978). Serial echocardiographic profiles in infants and children with goarctation of the aorta. The American Journal of Cardiology. 41(7). 1270–1277. 6 indexed citations
17.
Sahn, David J., Hugh D. Allen, Gail T. McDonald, & Stanley J. Goldberg. (1977). Real-time cross-sectional echocardiographic diagnosis of coarctation of the aorta: a prospective study of echocardiographic-angiographic correlations.. Circulation. 56(5). 762–769. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jameel Singh Breakdown of academic impact, for papers by Luis Sanfrutos Breakdown of academic impact, for papers by Ali Yavuzcan Breakdown of academic impact, for papers by Aida Moeini Breakdown of academic impact, for papers by Kemal Beksaç Breakdown of academic impact, for papers by Bonnia Liu Breakdown of academic impact, for papers by Andrea Bosio Breakdown of academic impact, for papers by Letícia Gonçalves Freitas Breakdown of academic impact, for papers by Francesca Colonese Breakdown of academic impact, for papers by Maria Komisarenko
Rankless by CCL
2026